Ovoca Bio $6.2 million acquisition of Ivix

12/7/2018

Public acquisition

Value:

$ 6.2 million

Status:

Completed

Date:

12/7/2018

Overview:

Irish company Ovoca Gold has acquired Russian biopharmaceutical company IVIX for $6.2 million.
Following the acquisition, Ovoca Gold has rebranded itself as Ovoca Bio focusing on pharmaceutical and life sciences sector.

Rajeeb Gurung - Researcher

Jurisdiction:

Ireland

Deal type:

Public acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firm:

OBH Partners

Party: Ovoca Bio (Acquirer)

Lawyer: Orlaith O'Brien

Related deals